Your browser doesn't support javascript.
loading
The role of the microbiome in gastrointestinal inflammation.
Sanders, David J; Inniss, Saskia; Sebepos-Rogers, Gregory; Rahman, Farooq Z; Smith, Andrew M.
Afiliación
  • Sanders DJ; Department of Microbial Diseases, UCL Eastman Dental Institute, Royal Free Campus, University College London, London, United Kingdom.
  • Inniss S; Department of Microbial Diseases, UCL Eastman Dental Institute, Royal Free Campus, University College London, London, United Kingdom.
  • Sebepos-Rogers G; Department of Microbial Diseases, UCL Eastman Dental Institute, Royal Free Campus, University College London, London, United Kingdom.
  • Rahman FZ; Department of Gastroenterology, University College London Hospitals NHS Foundation Trust, 250 Euston Road, London NW1 2PG, United Kingdom.
  • Smith AM; Department of Microbial Diseases, UCL Eastman Dental Institute, Royal Free Campus, University College London, London, United Kingdom.
Biosci Rep ; 41(6)2021 06 25.
Article en En | MEDLINE | ID: mdl-34076695
ABSTRACT
The microbiome plays an important role in maintaining human health. Despite multiple factors being attributed to the shaping of the human microbiome, extrinsic factors such diet and use of medications including antibiotics appear to dominate. Mucosal surfaces, particularly in the gut, are highly adapted to be able to tolerate a large population of microorganisms whilst still being able to produce a rapid and effective immune response against infection. The intestinal microbiome is not functionally independent from the host mucosa and can, through presentation of microbe-associated molecular patterns (MAMPs) and generation of microbe-derived metabolites, fundamentally influence mucosal barrier integrity and modulate host immunity. In a healthy gut there is an abundance of beneficial bacteria that help to preserve intestinal homoeostasis, promote protective immune responses, and limit excessive inflammation. The importance of the microbiome is further highlighted during dysbiosis where a loss of this finely balanced microbial population can lead to mucosal barrier dysfunction, aberrant immune responses, and chronic inflammation that increases the risk of disease development. Improvements in our understanding of the microbiome are providing opportunities to harness members of a healthy microbiota to help reverse dysbiosis, reduce inflammation, and ultimately prevent disease progression.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bacterias / Microbioma Gastrointestinal / Enfermedades Gastrointestinales / Intestinos Idioma: En Revista: Biosci Rep Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bacterias / Microbioma Gastrointestinal / Enfermedades Gastrointestinales / Intestinos Idioma: En Revista: Biosci Rep Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido